Mehdi Djelloul

Mehdi Djelloul

Auto-generated profile, based on publicly available information

Mehdi Djelloul

Stem Cell Laboratory for CNS Disease Modeling, Wallenberg Neuroscience Center, Department of Experimental Medical Science, BMC A10, Lund University, 22184 Lund, Sweden; Strategic Research Area MultiPark, Lund University, 22184 Lund, Sweden; Lund Stem Cell Center, Lund University, 22184 Lund, Sweden

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2019 in Nature
Verified
Journal Article
Closed access
PDF file
MYMaggie S. Y. Yeung
Maggie S. Y. Yeung
MDMehdi Djelloul
Mehdi Djelloul
ESEmbla Steiner
Embla Steiner
SBSamuel Bernard
Samuel Bernard
MSMehran Salehpour
Mehran Salehpour
JFJonas Frisén
Jonas Frisén

1 August 2015 in Stem Cell Reports
Verified
Journal Article
Open access
MDMehdi Djelloul
Mehdi Djelloul
SHStaffan Holmqvist
Staffan Holmqvist
ABAntonio Boza-Serrano
Antonio Boza-Serrano
CACarla Azevedo
Carla Azevedo
MYMaggie S. Yeung
Maggie S. Yeung
Laurent RoybonLaurent Roybon
Laurent Roybon
In this study, we sought evidence for alpha-synuclein (ASYN) expression in oligodendrocytes, as a possible endogenous source of ASYN to explain its presence in glial inclusions found in multiple system atrophy (MSA) and Parkinson's disease (PD). We identified ASYN in oligodendrocyte lineage progenitors isolated from the rodent brain, in oligodendrocytes generated from embryonic stem cells, and in induced pluripotent stem cells produced from fibroblasts of a healthy individual and patients diagnosed with MSA or PD, in cultures in vitro. Notably, we observed a significant decrease in ΑSYN during oligodendrocyte maturation. Additionally, we show the presence of transcripts in PDGFRΑ/CD140a(+) cells and SOX10(+) oligodendrocyte lineage nuclei isolated by FACS from rodent and human healthy and diseased brains, respectively. Our work identifies ASYN in oligodendrocyte lineage cells, and it offers additional in vitro cellular models that should provide significant insights of the functional implication of ASYN during oligodendrocyte development and disease.

2 June 2016 in npj Parkinson's Disease
Verified
Journal Article
Open access
SHStaffan Holmqvist
Staffan Holmqvist
SLSarka Lehtonen
Sarka Lehtonen
MCMargarita Chumarina
Margarita Chumarina
KPKatja A Puttonen
Katja A Puttonen
CACarla Azevedo
Carla Azevedo
Laurent RoybonLaurent Roybon
Laurent Roybon
Induced pluripotent stem cells (iPSCs) are becoming an important source of pre-clinical models for research focusing on neurodegeneration. They offer the possibility for better understanding of common and divergent pathogenic mechanisms of brain diseases. Moreover, iPSCs provide a unique opportunity to develop personalized therapeutic strategies, as well as explore early pathogenic mechanisms, since they rely on the use of patients’ own cells that are otherwise accessible only post-mortem, when neuronal death-related cellular pathways and processes are advanced and adaptive. Neurodegenerative diseases are in majority of unknown cause, but mutations in specific genes can lead to familial forms of these diseases. For example, mutations in the superoxide dismutase 1 gene lead to the motor neuron disease amyotrophic lateral sclerosis (ALS), while mutations in the SNCA gene encoding for alpha-synuclein protein lead to familial Parkinson’s disease (PD). The generations of libraries of familial human ALS iPSC lines have been described, and the iPSCs rapidly became useful models for studying cell autonomous and non-cell autonomous mechanisms of the disease. Here we report the generation of a comprehensive library of iPSC lines of familial PD and an associated synucleinopathy, multiple system atrophy (MSA). In addition, we provide examples of relevant neural cell types these iPSC can be differentiated into, and which could be used to further explore early disease mechanisms. These human cellular models will be a valuable resource for identifying common and divergent mechanisms leading to neurodegeneration in PD and MSA.

1 January 2012 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
MFMarie-Solenne Felix
Marie-Solenne Felix
NPNatalia Popa
Natalia Popa
MDMehdi Djelloul
Mehdi Djelloul
JBJosé Boucraut
José Boucraut
PGPatrick Gauthier
Patrick Gauthier
VMValery A. Matarazzo
Valery A. Matarazzo
Spinal cord injury (SCI) triggers a complex cellular response at the injury site, leading to the formation of a dense scar tissue. Despite this local tissue remodeling, the consequences of SCI at the cellular level in distant rostral sites (i.e., brain), remain unknown. In this study, we asked whether cervical SCI could alter cell dynamics in neurogenic areas of the adult rat forebrain. To this aim, we quantified BrdU incorporation and determined the phenotypes of newly generated cells (neurons, astrocytes, or microglia) during the subchronic and chronic phases of injury. We find that subchronic SCI leads to a reduction of BrdU incorporation and neurogenesis in the olfactory bulb and in the hippocampal dentate gyrus. By contrast, subchronic SCI triggers an increased BrdU incorporation in the dorsal vagal complex of the hindbrain, where most of the newly generated cells are identified as microglia. In chronic condition 90 days after SCI, BrdU incorporation returns to control levels in all regions examined, except in the hippocampus, where SCI produces a long-term reduction of neurogenesis, indicating that this structure is particularly sensitive to SCI. Finally, we observe that SCI triggers an acute inflammatory response in all brain regions examined, as well as a hippocampal-specific decline in BDNF levels. This study provides the first demonstration that forebrain neurogenesis is vulnerable to a distal SCI.

1 March 2014 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
SGStéphanie Gaigé
Stéphanie Gaigé
MDMehdi Djelloul
Mehdi Djelloul
CTCatherine Tardivel
Catherine Tardivel
CACoraline Airault
Coraline Airault
BFBernadette Félix
Bernadette Félix
MDMichel Dallaporta
Michel Dallaporta

30 June 2016 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
ADAdel Derghal
Adel Derghal
MDMehdi Djelloul
Mehdi Djelloul
JTJérôme Trouslard
Jérôme Trouslard
LMLourdes Mounien
Lourdes Mounien
Endocrine-disrupting chemicals (EDCs) are diverse natural and synthetic chemicals that may alter various mechanisms of the endocrine system and produce adverse developmental, reproductive, metabolic and neurological effects in both humans and wildlife. Research on EDCs has revealed that they use a variety of both nuclear receptor-mediated and non-receptor-mediated mechanisms to modulate different components of the endocrine system. The molecular mechanisms underlying the effects of EDCs are still under investigation. Interestingly, some of the effects of EDCs have been observed to pass on to subsequent unexposed generations, which can be explained by the gametic transmission of deregulated epigenetic marks. Epigenetics is the study of heritable changes in gene expression that occur without a change in the DNA sequence. Epigenetic mechanisms, including histone modifications, DNA methylation and specific micro-RNAs (miRNAs) expression, have been proposed to mediate transgenerational transmission and can be triggered by environmental factors. MiRNAs are short noncoding RNA molecules that post-transcriptionally repress the expression of genes by binding to 3′-untranslated regions of the target mRNAs. Given that there is mounting evidence that miRNAs are regulated by hormones, then clearly it is important to investigate the potential for environmental EDCs to deregulate miRNA expression and action.